Improving Sleep and Reducing External Stimuli With the Maya

Sponsor
Radboud University Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05078645
Collaborator
(none)
20
2
12

Study Details

Study Description

Brief Summary

Lack of sleep is a large problem for many patients in hospitals. Common causes are nuisances by light and sound. Especially with critically ill patients in the Intensive Care unit (ICU), Medium Care Unit (MCU) and Cardiac Care Unit (CCU), who are are monitored intensively, a lack of sleep often occurs.

Patients with a lack of sleep more offer suffer from delirium, are more often anxious and stressed, and have a longer length of stay in the hospital. Also, patients' lack of sleep enhances nurses workloads during nightshifts. Because of this, there is a strong need for innovative devices which aim to limit the light and sound nuisances and thereby enhance patients' quality of sleep in the ICU, MC and CCU.

The Maya is a special "cover" which can be placed over the head of the bed. As a result patients are able to limit light and sound nuisances and enhance their privacy.

With this pilot-study we aim to determine:
  • The feasibility and experiences of patients and healthcare professionals with the Maya.

  • To determine the effect size of dependent variables which can be used in future studies.

Condition or Disease Intervention/Treatment Phase
  • Device: Maya
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Pilot study with a crossover design. Half of the patients will use the Maya on the first, third and fifth day of their admission and will not use the maya on the second fourth and sixth day (group 1). The other half will use the Maya on the second, fourth and sixth day of their admission and will not use the maya on the first, third and fifth day (group 2). Group allocation will be randomised.Pilot study with a crossover design. Half of the patients will use the Maya on the first, third and fifth day of their admission and will not use the maya on the second fourth and sixth day (group 1). The other half will use the Maya on the second, fourth and sixth day of their admission and will not use the maya on the first, third and fifth day (group 2). Group allocation will be randomised.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Improving Sleep and Reducing External Stimuli With the Maya: a Pilot Study on Experience, Feasibility and Applicability
Anticipated Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Group 1: Maya use on 1st, 3th and 5th day

Group 1 uses the Maya on the 1st, 3th and 5th day and not on the 2nd, 4th and 6th day of their admission to either the ICU, MC or CCU.

Device: Maya
The Maya is a cover which can be placed over the end of the patients bed. The Maya aims to reduce light and sound nuisances and enhance patients' privacy

Other: Group 2: Maya use on the 2nd, 4th, and 6th day

Group 2 uses the Maya on the 2nd, 4th and 6th day and not on the 1st, 3th, and 5th day of their admission to either the ICU, MC or CCU.

Device: Maya
The Maya is a cover which can be placed over the end of the patients bed. The Maya aims to reduce light and sound nuisances and enhance patients' privacy

Outcome Measures

Primary Outcome Measures

  1. Quality of sleep [up to six days]

    patients' quality of sleep is measured once a day with the Richard Campbell Sleep Questionnaire (RCSQ); (minimum score 0 = worst sleep - maximum score 100 = best sleep)

Secondary Outcome Measures

  1. NRS sleep [up to six days]

    Patients' sleep is measured once a day with the sleep numeric rating scale (NRS sleep); (minimum score 0 = worst sleep - maximum score 10 = best sleep)

  2. Anxiety [up to six days]

    Patients' anxiety is measured once a day with the Daily Assesment of symptoms of Anxiety (DAS-A); (minimum score 0 = no anxiety - maximum score 24 = a lot of anxiety)

  3. NRS Stress [up to six days]

    Patients' stress is measured once a day with the stress numeric rating scale (NRS-stress); (minimum score 0 = no stress - maximum score 10 = most imaginable stress)

  4. Arousal [up to six days]

    patients' arousal is measured once a day with the Richmond Agitation Sedation Scale (RASS); (minimum score -5 = no reaction - maximum score = 4 very agitated)

  5. Delirium CCU [up to six days]

    CCU patients' delirium is measured once a day with the delirium observation scale (DOSS); (minimum score 0 = no delirium; a score of >= 3 means delirium; maximum score 65)

  6. Delirium ICU/MC [up to seven days]

    ICU/MC patients' delirium is measured once a day with the Intensive Care Delirium Checklist (ICDSC); (minimum score 0 = no delirium; a score of 1 - 3 means subsyndromal delirium; a score of 4 - 8 means delirium; maximum score 8)

  7. Light [up to six days]

    Light level (LUX). This will be measured with a validated application on a mobile phone

  8. Sound [up to six days]

    Sound levels (decibel). This will be measured with a validated application on a mobile phone

  9. Hart rate [up to six days]

    hart rate is measured with a heart rate monitor and reported every two hours as beats per minute (BPM)

  10. Respiratory rate [up to six days]

    Respiratory rate is measured every two hours with a respiratory rate monitor and reported as rate per minute

  11. oxygen saturation [up to six days]

    Oxygen saturation is measured every two hours with a oxygen saturation monitor and reported as a percentage

  12. Blood pressure [up to six days]

    Blood pressure is measured every two hours with a intra-arterial catheter or a bloodpressure cuff and reported as diastolic value and systolic value (mmHg)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult ICU, MC or CCU patients with 5 to 7 expected number of admission days

  • patients with an expected Richmond Agitation Sedation Scale (RASS) of >-3 and < +3

  • patients who speak Dutch (because of the qualitative evaluation of the Maya)

Exclusion Criteria:
  • patients with severe brain damage

  • patients with a severe psychiatric disorder

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Radboud University Medical Center

Investigators

  • Principal Investigator: Bram Tilburgs, Dr., adboudumc, intensive care, research

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bram Tilburgs, Principal Investigator, Radboud University Medical Center
ClinicalTrials.gov Identifier:
NCT05078645
Other Study ID Numbers:
  • 2021-13078
First Posted:
Oct 14, 2021
Last Update Posted:
Oct 14, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2021